First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer (FOIB)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01163396 |
Recruitment Status
:
Completed
First Posted
: July 15, 2010
Last Update Posted
: March 11, 2015
|
Sponsor:
Gruppo Oncologico del Nord-Ovest
Information provided by (Responsible Party):
Gruppo Oncologico del Nord-Ovest
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 2009 |
Actual Study Completion Date : | April 2010 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):